This topic contains a solution. Click here to go to the answer

Author Question: A client receiving chemotherapy for cancer has a hemoglobin level of 9.7 g/dL. Which of the ... (Read 78 times)

lidoalex

  • Hero Member
  • *****
  • Posts: 538
A client receiving chemotherapy for cancer has a hemoglobin level of 9.7 g/dL. Which of the following should the nurse anticipate as treatment for this client?
 
  1. Place client in reverse isolation.
  2. Administer antibiotics as prescribed.
  3. Administer epoetin alfa as prescribed.
  4. Administer filgrastim as prescribed.

Question 2

An adolescent female client being treated for cystic fibrosis is asking the nurse about birth control. Which of the following should the nurse include in these instructions?
 
  1. The chances that the client will become pregnant are small.
  2. Women with cystic fibrosis can transmit this disorder to their children.
  3. Pregnancy will cause the disease to go into remission.
  4. The client has a good chance of having children without the disorder.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

xoxo123

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

3
Treatment for moderate anemia in the client receiving chemotherapy for cancer would include the administration of epoetin alfa as prescribed. This medication elevates hemoglobin levels and improves the quality of life for clients. The other choices would be appropriate for the client diagnosed with neutropenia and not anemia.

Answer to Question 2

2
Infertility is not seen in women who are diagnosed with cystic fibrosis; therefore, a female with cystic fibrosis can transmit the disorder to her children. Infertility is common in adult men with cystic fibrosis. Pregnancy will not cause the disease to go into remission.




xoxo123

  • Sr. Member
  • ****
  • Posts: 335

 

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Your heart beats over 36 million times a year.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

For a complete list of videos, visit our video library